Argent Trust CO Royalty Pharma PLC Transaction History

Argent Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$26.21 - $29.22 $6,185 - $6,895	-236 Reduced 3.15%	7,259 $203,000
Q3 2023 Nov 08, 2023	SELL	$26.26 - $31.38 $39,390 - $47,070	-1,500 Reduced 16.68%	7,495 $203,000
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $34,661 - $42,811	1,171 Added 14.97%	8,995 $276,000
Q1 2023 May 12, 2023	SELL	$32.77 - $39.4 $24,380 - $29,313	-744 Reduced 8.68%	7,824 $281,000
Q4 2022 Feb 10, 2023	BUY	$39.17 - $44.04 $11,751 - $13,212	300 Added 3.63%	8,568 $338,000
Q3 2022 Nov 10, 2022	SELL	$39.88 - $44.65 $1,794 - $2,009	-45 Reduced 0.54%	8,268 $332,000
Q2 2022 Aug 11, 2022	SELL	$37.53 - $44.22 $4,278 - $5,041	-114 Reduced 1.35%	8,313 $349,000
Q1 2022 May 11, 2022	SELL	$37.46 - $42.44 $10,301 - $11,671	-275 Reduced 3.16%	8,427 $328,000
Q4 2021 Feb 09, 2022	BUY	$35.17 - $42.48 $306,049 - $369,660	8,702 New	8,702 $347,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

Stay updated on Argent Trust CO with notifications on news.